Ubiquitin enzymes in the regulation of immune responses

Critical Reviews in Biochemistry and Molecular Biology

Volumn 52, Issue 4, 2017, Pages 425-460

  Ebner, Petra ^a,c   Versteeg, Gijs A ^b,c   Ikeda, Fumiyo ^a,c  

^a INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^b CIBIV Center for Integrative Bioinformatics Vienna   (Austria)

^c Vienna Biocenter   (Austria)

Author keywords

B cell signaling; deubiquitinase; E3 ligase; T cell signaling; TNF signaling; TRIM; Ubiquitin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; OLIGOMER; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR; TRIPARTITE MOTIF PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; AUTOIMMUNITY; AUTOPHAGY; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UBIQUITINATION; IMMUNOLOGY; METABOLISM;

B-LYMPHOCYTES; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 85021392131     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409238.2017.1325829     Document Type: Review

References (303)

1. Abramson, J., and Goldfarb, Y., 2016. AIRE:from promiscuous molecular partnerships to promiscuous gene expression. European journal of immunology, 46, 22–33.
2. Aggarwal, B.B., 2003. Signalling pathways of the TNF superfamily:a double-edged sword. Nature reviews immunology, 3, 745–756.
3. Ahn, J., Ruiz, P., and Barber, G.N., 2014. Intrinsic self-DNA triggers inflammatory disease dependent on STING. Journal of immunology, 193, 4634–442.
4. Aireakiyama, T., et al., 2008. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity, 29, 423–437.
5. Akiyama, T., et al., 2005. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science, 308, 248–251.
6. Alin, K., and Goff, S.P., 1996. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology, 222, 339–351.
7. Anderson, M.S., et al., 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science, 298, 1395–1401.
8. Arimoto, K., et al., 2010. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proceedings of the national academy of sciences of the United States of America, 107, 15856–15861.
9. Asaoka, T., and Ikeda, F., 2015. New insights into the role of ubiquitin networks in the regulation of antiapoptosis pathways. International review of cell and molecular biology, 318, 121–158.
10. Ashkenazi, A., and Salvesen, G., 2014. Regulated cell death:signaling and mechanisms. Annual review of cell and developmental biology, 30, 337–356.
11. Bachmaier, K., et al., 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature, 403, 211–216.
12. Balagopalan, L., et al., 2007. c-Cbl-mediated regulation of LAT-nucleated signaling complexes. Molecular cell biology, 27, 8622–8636.
13. Beaudoin, M., et al., 2013. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS genetics, 9, e1003723.
14. Bell, J.L., et al., 2012. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members. PLoS One, 7, e37470.
15. Bennett, C.L., et al., 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature genetics, 27, 20–21.
16. Bharaj, P., et al., 2016. The matrix protein of Nipah virus targets the E3-ubiquitin ligase TRIM6 to inhibit the IKKepsilon kinase-mediated Type-I IFN antiviral response. PLoS pathogens, 12, e1005880.
17. Bhogaraju, S., et al., 2016. Phosphoribosylation of ubiquitin promotes serine ubiquitination and impairs conventional ubiquitination. Cell, 167, 1636–1649.e13.
18. Bhoj, V.G., and Chen, Z.J., 2009. Ubiquitylation in innate and adaptive immunity. Nature, 458, 430–437.
19. Birgisdottir, A.B., Lamark, T., and Johansen, T., 2013. The LIR motif–crucial for selective autophagy. Journal of cell science, 126, 3237–3247.
20. Bjorkoy, G., et al., 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. Journal of cellular biology, 171, 603–614.
21. Blair, P.J., et al., 1994. CD4 + CD8− T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. Journal of immunology, 153, 3764–3774.
22. Boname, J.M., et al., 2010. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic, 11, 210–220.
23. Bottomley, M.J., et al., 2005. NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1). Insights into autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) disease. Journal of biological chemistry, 280, 11505–11512.
24. Bremm, A., Freund, S.M., and Komander, D., 2010. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nature structural & molecular biology, 17, 939–947.
25. Brunkow, M.E., et al., 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature genetics, 27, 68–73.
26. Burdette, D.L., et al., 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature, 478, 515–518.
27. Cairns, T.M., and Craven, R.C., 2001. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants. Journal of virology, 75, 242–250.
28. Cao, Z., et al., 2015. Ubiquitin ligase TRIM62 regulates CARD9-mediated anti-fungal immunity and intestinal inflammation. Immunity, 43, 715–726.
29. Carpino, N., et al., 2009. The Sts proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways. Molecular immunology, 46, 3224–3231.
30. Carthagena, L., et al., 2009. Human TRIM gene expression in response to interferons. PLoS One, 4, e4894.
31. Chang, J.H., et al., 2012. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nature immunology, 13, 481–490.
32. Chang, J.H., et al., 2014. TRAF3 regulates the effector function of regulatory T cells and humoral immune responses. Journal of experimental medicine, 211, 137–151.
33. Chang, M., et al., 2011. The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nature immunology, 12, 1002–1009.
34. Chau, V., et al., 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science, 243, 1576–1583.
35. Chen, Z., et al., 2013. The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity, 39, 272–285.
36. Chen, Z.J., 2005. Ubiquitin signalling in the NF-kappaB pathway. Nature cell biology, 7, 758–765.
37. Chiang, Y.J., et al., 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature, 403, 216–220.
38. Chiffoleau, E., et al., 2003. TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease. Journal of immunology, 171, 5751–579.
39. Chu, Y., et al., 2011. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood, 117, 2227–2236.
40. Ciani, B., et al., 2010. Molecular basis of coiled-coil oligomerization-state specificity. Proceedings of the national academy of sciences of the United States of America, 107, 19850–19855.
41. Ciechanover, A., and Ben-Saadon, R., 2004. N-terminal ubiquitination:more protein substrates join in. Trends in cell biology, 14, 103–106.
42. Cook, W.J., et al., 1992. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). Journal of biological chemistry, 267, 16467–16471.
43. Coornaert, B., et al., 2008. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Natutre immunology, 9, 263–271.
44. Corcoran, K., et al., 2011. Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). Journal of biological chemistry, 286, 37168–37180.
45. Craven, R.C., et al., 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. Journal of virology, 69, 4213–4227.
46. Dai, L., et al., 2012. TAK1, more than just innate immunity. IUBMB life, 64, 825–834.
47. de Figueiredo-Pontes, L.L., et al., 2011. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway. PLoS One, 6, e26713.
48. Deng, L., et al., 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell, 103, 351–361.
49. Deshaies, R.J., and Joazeiro, C.A., 2009. RING domain E3 ubiquitin ligases. Annual review of biochemistry, 78, 399–434.
50. Diaz-Griffero, F., et al., 2006. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology, 349, 300–315.
51. Diaz-Griffero, F., et al., 2009. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction. Journal of virology, 83, 10737–10751.
52. Dikic, I., Wakatsuki, S., and Walters, K.J., 2009. Ubiquitin-binding domains–from structures to functions. Nature reviews molecular cell biology, 10, 659–671.
53. Dou, H., et al., 2012. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nature structural & molecular biology, 19, 876–883.
54. Dou, H., et al., 2013. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nature structural & molecular biology, 20, 982–986.
55. Dove, K.K., et al., 2016. Molecular insights into RBR E3 ligase ubiquitin transfer mechanisms. EMBO reports, 17, 1221–1235.
56. Duwel, M., et al., 2009. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. The journal of immunology, 182, 7718–7728.
57. Elliott, P.R., et al., 2014. Molecular basis and regulation of OTULIN-LUBAC interaction. Molecular cell, 54, 335–348.
58. Emmerich, C.H., et al., 2013. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proceedings of the national academy of sciences of the United States of America, 110, 15247–15252.
59. Espinosa, A., et al., 2009. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. Journal of experimental medicine, 206, 1661–1671.
60. Fang, D., and Liu, Y.C., 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nature immunology, 2, 870–875.
61. Fang, D., et al., 2002. Dysregulation of T lymphocyte function in itchy mice:a role for Itch in TH2 differentiation. Nature immunology, 3, 281–287.
62. Fiil, B.K., et al., 2013. OTULIN restricts met1-linked ubiquitination to control innate immune signaling. Molecular cell, 50, 818–830.
63. Finley, D., 2009. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annual review of biochemistry, 78, 477–513.
64. Fiskin, E., et al., 2017. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA. Nature communications, 8, 14004.
65. Fletcher, A.J., et al., 2015. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proceedings of the national academy of sciences of the United States of America, 112, 10014–10019.
66. Gack, M.U., et al., 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature, 446, 916–920.
67. Gack, M.U., et al., 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell host & microbe, 5, 439–449.
68. Ganser-Pornillos, B.K., et al., 2011. Hexagonal assembly of a restricting TRIM5alpha protein. Proceedings of the national academy of sciences of the United States of America, 108, 534–539.
69. Garcia-Sastre, A., et al., 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology, 252, 324–330.
70. Gerlach, B., et al., 2011. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature, 471, 591–596.
71. Germain, R.N., 2002. T-cell development and the CD4-CD8 lineage decision. Nature reviews immunology, 2, 309–322.
72. Giordano, M., et al., 2014. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proceedings of the national academy of sciences of the United States of America, 111, 11115–11120.
73. Goto, E., and Tokunaga, F., 2017. Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP. Biochemical and biophysical research communications, 485, 152–159.
74. Grice, G.L., et al., 2015. The proteasome distinguishes between heterotypic and homotypic lysine-11-linked polyubiquitin chains. Cell reports, 12, 545–553.
75. Grou, C.P., et al., 2015. The de novo synthesis of ubiquitin:identification of deubiquitinases acting on ubiquitin precursors. Scientific reports, 5, 12836.
76. Grutter, C., et al., 2006. Structure of the PRYSPRY-domain:implications for autoinflammatory diseases. FEBS letters, 580, 99–106.
77. Haas, T.L., et al., 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Molecular cell, 36, 831–844.
78. Hale, B.G., et al., 2008. The multifunctional NS1 protein of influenza A viruses. Journal of general virology, 89, 2359–2376.
79. Han, K., LOU, D.I., and SAWYER, S.L., 2011. Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS genetics, 7, e1002388.
80. Harada, Y., et al., 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. Journal of experimental medicine, 207, 1381–1391.
81. Hatakeyama, S., 2011. TRIM proteins and cancer. Nature reviews cancer, 11, 792–804.
82. Hatakeyama, S., 2017. TRIM family proteins:roles in autophagy, immunity, and carcinogenesis. Trends in biochemical sciences, 42, 297–311.
83. Hatziioannou, T., et al., 2004. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proceedings of the national academy of sciences of the United States of America, 101, 10774–10779.
84. Heesters, B.A., et al., 2016. Antigen presentation to B cells. Trends in immunology, 37, 844–854.
85. Heissmeyer, V., et al., 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature immunology, 5, 255–265.
86. Hicke, L., Schubert, H.L., and Hill, C.P., 2005. Ubiquitin-binding domains. Nature reviews molecular cell biology, 6, 610–621.
87. Hornung, V., et al., 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science, 314, 994–997.
88. Hospenthal, M.K., Mevissen, T.E., and Komander, D., 2015. Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest). Nature protocols, 10, 349–361.
89. Hrdinka, M., et al., 2016. CYLD limits Lys63- and Met1-linked ubiquitin at receptor complexes to regulate innate immune signaling. Cell reports, 14, 2846–2858.
90. Hu, H., et al., 2013. OTUD7B controls non-canonical NF-kappaB activation through deubiquitination of TRAF3. Nature, 494, 371–374.
91. Hu, H., and Sun, S.C., 2016. Ubiquitin signaling in immune responses. Cell research, 26, 457–483.
92. Hu, H., et al., 2016. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. Journal of experimental medicine, 213, 399–414.
93. Huang, H., et al., 2010. K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling. Immunity, 33, 60–70.
94. Husnjak, K., and Dikic, I., 2012. Ubiquitin-binding proteins:decoders of ubiquitin-mediated cellular functions. Annual review of biochemistry, 81, 291–322.
95. Ikeda, F., 2015. Linear ubiquitination signals in adaptive immune responses. Immunological reviews, 266, 222–236.
96. Ikeda, F., Crosetto, N., and Dikic, I., 2010. What determines the specificity and outcomes of ubiquitin signaling? Cell, 143, 677–681.
97. Ikeda, F., and Dikic, I., 2008. Atypical ubiquitin chains:new molecular signals. 'Protein Modifications:Beyond the Usual Suspects' review series. EMBO reports, 9, 536–542.
98. Ikeda, F., et al., 2011. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature, 471, 637–641.
99. Ishikawa, H., and Barber, G.N., 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature, 455, 674–678.
100. Ishikawa, H., Ma, Z., and Barber, G.N., 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature, 461, 788–792.
101. Iwai, K., and Tokunaga, F., 2009. Linear polyubiquitination:a new regulator of NF-kappaB activation. EMBO reports, 10, 706–713.
102. James, L.C., et al., 2007. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proceedings of the national academy of sciences of the United States of America, 104, 6200–6205.
103. Javanbakht, H., et al., 2005. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. Journal of biological chemistry, 280, 26933–26940.
104. Jeon, M.S., et al., 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity, 21, 167–177.
105. Jiang, X., et al., 2012. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity, 36, 959–973.
106. Johnson, E.S., et al., 1995. A proteolytic pathway that recognizes ubiquitin as a degradation signal. Journal of biological chemistry, 270, 17442–17456.
107. Kamanova, J., et al., 2016. The Salmonella effector protein SopA modulates innate immune responses by targeting TRIM E3 ligase family members. PLoS pathogens, 12, e1005552.
108. Kato, H., et al., 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 441, 101–105.
109. Keckesova, Z., Ylinen, L.M., and Towers, G.J., 2004. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proceedings of the national academy of sciences of the United States of America, 101, 10780–10785.
110. Keeble, A.H., et al., 2008. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proceedings of the national academy of sciences of the United States of America, 105, 6045–6050.
111. Keown, J.R., and Goldstone, D.C., 2016. Crystal structure of the Trim5alpha Bbox2 domain from rhesus macaques describes a plastic oligomerisation interface. Journal of structural biology, 195, 282–285.
112. Kim, H.T., et al., 2007. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. Journal of biological chemistry, 282, 17375–17386.
113. Kimura, T., et al., 2015. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. Journal of cell biology, 210, 973–989.
114. Kimura, T., et al., 2016. TRIM-directed selective autophagy regulates immune activation. Autophagy [online]. Available from:http://dx.doi.org/10.1080/15548627.2016.1154254
115. King, C.G., et al., 2006. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nature medicine, 12, 1088–1092.
116. King, C.G., et al., 2008. Cutting edge:requirement for TRAF6 in the induction of T cell anergy. Journal of immunology, 180, 34–38.
117. Kirisako, T., et al., 2006. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO journal, 25, 4877–4887.
118. Kobayashi, T., et al., 2009. TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS One, 4, e4736.
119. Koliopoulos, M.G., et al., 2016. Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO journal, 35, 1204–1218.
120. Komander, D., and Rape, M., 2012. The ubiquitin code. Annual review of biochemistry, 81, 203–229.
121. Komander, D., et al., 2009. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO reports, 10, 466–473.
122. Kontgen, F., et al., 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes development, 9, 1965–1977.
123. Koyano, F., et al., 2014. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature, 510, 162–166.
124. Kulathu, Y., et al., 2009. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nature structural & molecular biology, 16, 1328–1330.
125. Kumari, S., et al., 2014. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. Elife, 3, e03422.
126. Kwon, H., et al., 1998. Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. Journal of biological chemistry, 273, 7431–7440.
127. Lang, X., et al., 2017. TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity. Journal of experimental medicine, 214, 459–473.
128. Lechtenberg, B.C., et al., 2016. Structure of a HOIP/E2∼ubiquitin complex reveals RBR E3 ligase mechanism and regulation. Nature, 529, 546–550.
129. Lee, J.H., et al., 2015. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1alpha to maintain regulatory T cell stability and suppressive capacity. Immunity, 42, 1062–1074.
130. Leppek, K., et al., 2013. Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell, 153, 869–881.
131. Li, X., and Sodroski, J., 2008. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. Journal of virology, 82, 11495–11502.
132. Li, Y., Kar, A.K., and Sodroski, J., 2009. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. Journal of virology, 83, 10951–10962.
133. Li, Y.L., et al., 2016. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids. *Elife, 5.
134. Lienlaf, M., et al., 2011. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh):structure of the RING domain of TRIM5alpha. Journal of virology, 85, 8725–8737.
135. Lineberry, N.B., et al., 2008. Cutting edge:the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. Journal of immunology, 181, 1622–1626.
136. Liou, H.C., et al., 1999. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. International immunology, 11, 361–371.
137. Liu, C., et al., 2017. Ufd2p synthesizes branched ubiquitin chains to promote the degradation of substrates modified with atypical chains. Nature communications, 8, 14274.
138. Liu, X., et al., 2013. USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. Journal of experimental medicine, 210, 1575–1590.
139. Lohr, N.J., et al., 2010. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. American journal of human genetics, 86, 447–453.
140. Lopitz-Otsoa, F., Rodriguez, M.S., and Aillet, F., 2010. Properties of natural and artificial proteins displaying multiple ubiquitin-binding domains. Biochemical society transactions, 38, 40–45.
141. Lu, Y., et al., 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology, 214, 222–228.
142. Lupher, M.L., Jr, et al., 1996. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. Journal of biological chemistry, 271, 24063–24068.
143. Mackenzie, D.A., et al., 2007. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. Journal of biological chemistry, 282, 9696–96702.
144. Maggirwar, S.B., Harhaj, E.W., and Sun, S.C., 1997. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors. Molecular and cellular biology, 17, 2605–2614.
145. Malfavon-Borja, R., et al., 2013. An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome biology and evolution,5, 2141–2154.
146. Mallery, D.L., et al., 2010. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proceedings of the national academy of sciences of the United States of America, 107, 19985–19990.
147. Malynn, B.A., and Ma, A., 2010. Ubiquitin makes its mark on immune regulation. Immunity, 33, 843–852.
148. Mandell, M.A., et al., 2014a. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Developmental cell, 30, 394–409.
149. Mandell, M.A., et al., 2014b. TRIM proteins regulate autophagy:TRIM5 is a selective autophagy receptor mediating HIV-1 restriction. Autophagy, 10, 2387–2388.
150. Mandell, M.A., et al., 2016. TRIM17 contributes to autophagy of midbodies while actively sparing other targets from degradation. Journal of cell science, 129, 3562–3573.
151. Martinez, F.O., et al., 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization:new molecules and patterns of gene expression. Journal of immunology, 177, 7303–7311.
152. Masuda, Y., et al., 2015. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. Nature communications, 6, 7299.
153. Matsumoto, M.L., et al., 2010. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Molecular cell, 39, 477–484.
154. Matsuzawa, A., et al., 2008. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science, 321, 663–668.
155. Mcewan, W.A., et al., 2013. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nature immunology, 14, 327–336.
156. Metzger, M.B., Hristova, V.A., and Weissman, A.M., 2012. HECT and RING finger families of E3 ubiquitin ligases at a glance. Journal of cellular science, 125, 531–537.
157. Metzger, M.B., et al., 2014. RING-type E3 ligases:master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochimica et biophysica acta, 1843, 47–60.
158. Mevissen, T.E., et al., 2016. Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne. Nature, 538, 402–405.
159. Meyer, H.J., and Rape, M., 2014. Enhanced protein degradation by branched ubiquitin chains. Cell, 157, 910–921.
160. Michelle, C., et al., 2009. What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor? Journal of molecular evolution, 68, 616–628.
161. Nagamine, K., et al., 1997. Positional cloning of the APECED gene. Nature genetics, 17, 393–398.
162. Naik, E., et al., 2014. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. Journal of experimental medicine, 211, 1947–1955.
163. Nemeroff, M.E., et al., 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Molecular cell, 1, 991–1000.
164. Neumann, M., and Naumann, M., 2007. Beyond IkappaBs:alternative regulation of NF-kappaB activity. FASEB journal, 21, 2642–2654.
165. Nisole, S., et al., 2013. Differential Roles of PML Isoforms. Frontiers in oncology, 3, 125.
166. Nurieva, R.I., et al., 2010. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity, 32, 670–680.
167. Oh, J., et al., 2013. MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. Journal of experimental medicine, 210, 1069–1077.
168. Ohtake, F., et al., 2015. Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO reports, 16, 192–201.
169. Ordureau, A., Munch, C., and Harper, J.W., 2015. Quantifying ubiquitin signaling. Molecular cell, 58, 660–676.
170. Ordureau, A., et al., 2008. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochemical journal, 409, 43–52.
171. Ouyang, S., et al., 2012. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity, 36, 1073–1086.
172. Owen, K.A., Anderson, C.J., and Casanova, J.E., 2016. Salmonella suppresses the TRIF-dependent type I interferon response in macrophages. MBio, 7, e02051–15.
173. Ozato, K., et al., 2008. TRIM family proteins and their emerging roles in innate immunity. Nature reviews immunology, 8, 849–860.
174. Ozato, K., et al., 2009. Comment on "Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappa B-dependent cytokine expression in fibroblasts". Journal of immunology, 183, 7619. 3RD author reply 720-1.
175. Pankiv, S., et al., 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. Journal of biological chemistry, 282, 24131–24145.
176. Paolino, M., et al., 2011. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions. Journal of immunology, 186, 2138–2147.
177. Park, Y., et al., 2014. The ubiquitin system in immune regulation. Advances in immunology, 124, 17–66.
178. Park, Y., Jin, H.S., and Liu, Y.C., 2013. Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex. Proceedings of the national academy of sciences of the United States of America, 110, 9433–9438.
179. Peisley, A., et al., 2014. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature, 509, 110–114.
180. Peltzer, N., et al., 2014. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell reports, 9, 153–165.
181. Perron, M.J., et al., 2004. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proceedings of the national academy of sciences of the United States of America, 101, 11827–11832.
182. Perry, W.L., et al., 1998. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nature genetics, 18, 143–146.
183. Pertel, T., et al., 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature, 472, 361–365.
184. Pichlmair, A., et al., 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science, 314, 997–1001.
185. Pratama, A., et al., 2013. Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity, 38, 669–680.
186. Pruneda, J.N., et al., 2012. Structure of an E3:E2∼Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Molecular cell, 47, 933–942.
187. Qian, Y., et al., 2008. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome. European journal of immunology, 38, 2219–2228.
188. Qian, Y., et al., 2004. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity, 21, 575–587.
189. Qiu, J., et al., 2016. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors. Nature, 533, 120–124.
190. Quinto, I., et al., 1999. Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development. Journal of biological chemistry, 274, 17567–17572.
191. Rahighi, S., et al., 2009. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell, 136, 1098–1109.
192. Rajsbaum, R., Garcia-Sastre, A., and Versteeg, G.A., 2014a. TRIMmunity:the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. Journal of molecular biology, 426, 1265–1284.
193. Rajsbaum, R., Stoye, J.P., and O'Garra, A., 2008. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. European journal of immunology, 38, 619–630.
194. Rajsbaum, R., et al., 2014b. Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKepsilon kinase-mediated antiviral response. Immunity, 40, 880–895.
195. Rakebrandt, N., et al., 2014. Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica. Pathogens and disease, 72, 131–137.
196. Rauch, J., et al., 2011. The secret life of kinases:functions beyond catalysis. Cell communication and signaling, 9, 23.
197. Reiley, W.W., et al., 2007. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. Journal of experimental medicine, 204, 1475–1485.
198. Reiley, W.W., et al., 2006. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nature immunology, 7, 411–417.
199. Reissig, S., et al., 2012. The tumor suppressor CYLD controls the function of murine regulatory T cells. Journal of immunology, 189, 4770–4776.
200. Reyes-Turcu, F.E., Ventii, K.H., and Wilkinson, K.D., 2009. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annual review of biochemistry, 78, 363–397.
201. Reymond, A., et al., 2001. The tripartite motif family identifies cell compartments. EMBO journal, 20, 2140–2151.
202. Rhodes, D.A., and Trowsdale, J., 2007. TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Molecular immunology, 44, 2406–2414.
203. Rickard, J.A., et al., 2014. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. Elife, 3, e03464.
204. Rivas, M.A., et al., 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nature genetics, 43, 1066–1073.
205. Roa, A., et al., 2012. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. Journal of virology, 86, 1717–1727.
206. Rold, C.J., and Aiken, C., 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS pathogens, 4, e1000074.
207. Rowland, S.L., et al., 2007. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. Journal of immunology, 179, 4645–4653.
208. Sakaguchi, S., et al., 2008. Regulatory T cells and immune tolerance. Cell, 133, 775–787.
209. Sanchez, J.G., et al., 2014. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proceedings of the national academy of sciences of the United States of America, 111, 2494–2499.
210. Sato, Y., et al., 2009. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3. EMBO journal, 28, 3903–3909.
211. Sawyer, S.L., et al., 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proceedings of the national academy of sciences of the United States of America, 102, 2832–2837.
212. Schaeffer, V., et al., 2014. Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. Molecular cell, 54, 349–361.
213. Scharschmidt, E., et al., 2004. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Molecular and cellular biology, 24, 3860–3873.
214. Scheffner, M., and Kumar, S., 2014. Mammalian HECT ubiquitin–protein ligases:biological and pathophysiological aspects. Biochimica et biophysica acta, 1843, 61–74.
215. Scherer, M., and Stamminger, T., 2016. Emerging role of PML nuclear bodies in innate immune signaling. Journal of virology, 90, 5850–5854.
216. Schulman, B.A., and Harper, J.W., 2009. Ubiquitin-like protein activation by E1 enzymes:the apex for downstream signalling pathways. Nature reviews molecular cell biology, 10, 319–331.
217. Schwartzkopff, B., Platta, H.W., and Girzalsky, W., 2015. Cystein-specific ubiquitination protects the peroxisomal import receptor Pex5p against proteasomal degradation. Bioscience reports, 35, e00215.
218. Seymour, R.E., et al., 2007. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes immunology, 8, 416–421.
219. Shu, C, et al., 2012. Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nature structural & molecular biology, 19, 722–724.
220. Sims, J.J., and Cohen, R.E., 2009. Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of rap80. Molecular cell, 33, 775–783.
221. Smit, J.J., and Sixma, T.K., 2014. RBR E3-ligases at work. EMBO reports, 15, 142–154.
222. Smith-Garvin, J.E., Koretzky, G.A., and Jordan, M.S., 2009. T cell activation. Annual review immunology, 27, 591–619.
223. Song, R., et al., 2008. Mind bomb 1 in the lymphopoietic niches is essential for T and marginal zone B cell development. Journal of experimental medicine, 205, 2525–2536.
224. Spratt, D.E., Walden, H., and Shaw, G.S., 2014. RBR E3 ubiquitin ligases:new structures, new insights, new questions. Biochemical journal, 458, 421–437.
225. Stempin, C.C., et al., 2011. The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation. Journal of biological chemistry, 286, 37147–37157.
226. Stieglitz, B., et al., 2013. Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature, 503, 422–426.
227. Streich FC, Jr., et al., 2013. Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism. Journal of biological chemistry, 288, 8209–8221.
228. Stremlau, M., et al., 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature, 427, 848–853.
229. Stremlau, M., et al., 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proceedings of the national academy of sciences of the United States of America, 103, 5514–5519.
230. Su, L., et al., 2006. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. Journal of immunology, 177, 7559–7566.
231. Sun, L., et al., 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Molecular cell, 14, 289–301.
232. Sun, L., et al., 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science, 339, 786–791.
233. Swatek, K.N., and Komander, D., 2016. Ubiquitin modifications. Cell research, 26, 399–422.
234. Takiuchi, T., et al., 2014. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes cells, 19, 254–272.
235. Tavares, R.M., et al., 2010. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity, 33, 181–191.
236. Tenno, T., et al., 2004. Structural basis for distinct roles of Lys63-and Lys48-linked polyubiquitin chains. Genes cells, 9, 865–875.
237. Tenoever, B.R., et al., 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science, 315, 1274–1278.
238. Tokunaga, F., et al., 2009. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nature cell biology, 11, 123–132.
239. Tokunaga, F., et al., 2012. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO journal, 31, 3856–3870.
240. Tsagaratou, A., et al., 2010. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner. Journal of immunology, 185, 2032–2043.
241. Tsuchida, T., et al., 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity, 33, 765–776.
242. Uchida, D., et al., 2004. AIRE functions as an E3 ubiquitin ligase. Journal of experimental medicine, 199, 167–172.
243. Uchil, P.D., et al., 2013. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. Journal of virology, 87, 257–272.
244. Vallabhapurapu, S., et al., 2008. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nature immunology, 9, 1364–1370.
245. van Loosdregt, J., et al., 2013. Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity, 39, 259–271.
246. van Valen, L., 1973. A new evolutionary law. Evolutionary theory, 1, 1–30.
247. van Wijk, S.J., et al., 2012. Fluorescence-based sensors to monitor localization and functions of linear and K63-linked ubiquitin chains in cells. Molecular cell, 47, 797–809.
248. Varadan, R., et al., 2002. Structural properties of polyubiquitin chains in solution. Journal of molecular biology, 324, 637–647.
249. Varfolomeev, E., and Vucic, D., 2016. Intracellular regulation of TNF activity in health and disease. Cytokine [online]. Available from:http://dx.doi.org/10.1016/j.cyto.2016.08.035
250. Vaysburd, M., et al., 2013. Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proceedings of the national academy of sciences of the United States of America, 110, 12397–12401.
251. Venuprasad, K., et al., 2008. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nature immunology, 9, 245–253.
252. Verhelst, K., et al., 2012. A20 inhibits LUBAC-mediated NF-kappaB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO journal, 31, 3845–3855.
253. Versteeg, G.A., and Garcia-Sastre, A., 2010. Viral tricks to grid-lock the type I interferon system. Current opinion microbiology, 13, 508–516.
254. Versteeg, G.A., et al., 2013. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity, 38, 384–398.
255. Versteeg, G.A., et al., 2014. InTRIMsic immunity:positive and negative regulation of immune signaling by tripartite motif proteins. *Cytokine Growth Factor Review, 25, 563–576.
256. Vijay-Kumar, S., Bugg, C.E., and Cook, W.J., 1987. Structure of ubiquitin refined at 1.8 A resolution. Journal of molecular biology, 194, 531–544.
257. Vinuesa, C.G., et al., 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nature reviews immunology, 5, 853–865.
258. Virdee, S., et al., 2010. Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nature chemical biology, 6, 750–757.
259. Vogel, K.U., et al., 2013. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity, 38, 655–668.
260. Vucic, D., Dixit, V.M., and Wertz, I.E., 2011. Ubiquitylation in apoptosis:a post-translational modification at the edge of life and death. Nature reviews molecular cell biology, 12, 439–452.
261. Wahren, M., et al., 1998. Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus. Journal of autoimmunology, 11, 29–38.
262. Walczak, H., 2011. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunological reviews, 244, 9–28.
263. Wang, D., et al., 2012. Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells. Proceedings of the national academy of sciences of the United States of America, 109, 9493–9498.
264. Wang, X., et al., 2007. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. Journal of cell biology, 177, 613–624.
265. Watkinson, R.E., et al., 2015. TRIM21 promotes cGAS and RIG-I sensing of viral genomes during infection by antibody-opsonized virus. PLoS pathogens, 11, e1005253.
266. Weeks, S.D., et al., 2009. Crystal structures of Lys-63-linked tri- and di-ubiquitin reveal a highly extended chain architecture. Proteins, 77, 753–759.
267. Weinert, C., et al., 2009. The crystal structure of human pyrin b30.2 domain:implications for mutations associated with familial Mediterranean fever. Journal of molecular biology, 394, 226–236.
268. Wenzel, D.M., et al., 2011. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature, 474, 105–108.
269. Wertz, I.E., et al., 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature, 430, 694–699.
270. Wertz, I.E., et al., 2015. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature, 528, 370–375.
271. Wiborg, O., et al., 1985. The human ubiquitin multigene family:some genes contain multiple directly repeated ubiquitin coding sequences. EMBO journal, 4, 755–759.
272. Wild, P., et al., 2011. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science, 333, 228–233.
273. Wildin, R.S., et al., 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature genetics, 27, 18–20.
274. Wilkinson, K.D., et al., 1995. Metabolism of the polyubiquitin degradation signal:structure, mechanism, and role of isopeptidase T. Biochemistry, 34, 14535–14546.
275. Wohlfert, E.A., et al., 2006. Cutting edge:deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. Journal of immunology, 176, 1316–1320.
276. Woo, J.S., et al., 2006. Structural and functional insights into the B30.2/SPRY domain. EMBO journal, 25, 1353–1363.
277. Wu, J., and Chen, Z.J., 2014. Innate immune sensing and signaling of cytosolic nucleic acids. Annual reviews immunology, 32, 461–488.
278. Wu, X., et al., 2006. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proceedings of the national academy of sciences of the United States of America, 103, 7465–7470.
279. Xing, J., et al., 2016. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nature immunology, 17, 1373–1380.
280. Xing, Y., and Hogquist, K.A., 2012. T-cell tolerance:central and peripheral. Cold spring harbor perspectives in biology, 4, a006957.
281. Xu, L., et al., 2003. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Experimental cell research, 288, 84–93.
282. Xu, Y., Cheng, G., and Baltimore, D., 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity, 5, 407–415.
283. Yamamoto, M., et al., 2006. Cutting edge:pivotal function of Ubc13 in thymocyte TCR signaling. Journal of immunology, 177, 7520–7524.
284. Yamano, K., Matsuda, N., and Tanaka, K., 2016. The ubiquitin signal and autophagy:an orchestrated dance leading to mitochondrial degradation. EMBO reports, 17, 300–316.
285. Yang, M., et al., 2015. K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation. Nature immunology, 16, 1253–1262.
286. Yau, R., and Rape, M., 2016. The increasing complexity of the ubiquitin code. Nature cell biology, 18, 579–586.
287. Ye, Y., and Rape, M., 2009. Building ubiquitin chains:E2 enzymes at work. Nature reviews molecular cell biology, 10, 755–764.
288. Yeh, W.C., et al., 1997. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7, 715–725.
289. Yi, Z., et al., 2014a. The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2. Nature immunology, 15, 866–874.
290. Yi, Z., et al., 2014b. TRAF3 regulates homeostasis of CD8+ central memory T cells. PLoS One, 9, e102120.
291. Yoneyama, M., et al., 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature immunology, 5, 730–737.
292. Yoshimi, R., et al., 2009. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. Journal of immunology, 182, 7527–7538.
293. Yu, D., et al., 2007a. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature, 450, 299–303.
294. Yu, J.W., et al., 2007b. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Molecular cell, 28, 214–227.
295. Zeng, W., et al., 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell, 141, 315–330.
296. Zhang, J., et al., 2006. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. Journal of clinical investigation, 116, 3042–3049.
297. Zhang, L., et al., 2011. Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappaB activation. Nature, 481, 204–208.
298. Zhang, M., et al., 2005. Chaperoned ubiquitylation–crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Molecular cell, 20, 525–538.
299. Zhao, Y., et al., 2011. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells. Journal of biological chemistry, 286, 40520–40530.
300. Zhou, H., et al., 2004. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature, 427, 167–171.
301. Zhou, X.Y., et al., 2002. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. Journal of immunology, 168, 3847–3854.
302. Zinngrebe, J., et al., 2014. Ubiquitin in the immune system. EMBO reports, 15, 28–45.
303. Zou, Q., et al., 2014. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nature immunology, 15, 562–570.